Evidence map›Paper›PMID 42860618›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Drug Repurposing for Treating NCOR-Related Intellectual Disability.

Yan Kong, Wenjun Zhou, Yuxiang Sun, Zihan Huang, Zhiyue Liu, Udhaya Kumar S, Chenyan Li, Yi Lu, Chengchuang Song, Veronica C Ciliberto and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yan Kong *Department of Biochemistry and Molecular Biology, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Wenjun Zhou *Department of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-8268-0251
Yuxiang Sun *Department of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0009-0002-0915-6557
Zihan HuangDepartment of Biochemistry and Molecular Biology, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
Zhiyue LiuDepartment of Pediatrics, Shandong University Qilu Hospital, Jinan, Shandong, China.
Udhaya Kumar SDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-6639-3746
Chenyan LiMyGenostics Inc., Beijing, China.
Yi LuDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.
Chengchuang SongDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.
Veronica C CilibertoDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-7828-4248
Makenna MackDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.
Lana E KimDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0009-0003-4084-1277
Zhaoyong HuDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-4171-3587
Fang LuoMyGenostics Inc., Beijing, China.
Aihua CaoDepartment of Pediatrics, Shandong University Qilu Hospital, Jinan, Shandong, China.
Zheng SunDepartment of Medicine - Division of Endocrinology, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-6858-0633

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Casey W Wright · 2019 to 2026
$14.7M
Training in Precision Environmental Health SciencesT32ES027801 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2018 to 2026
$2.8M
Inter- and transgenerational effects of paternal arsenic exposureR01ES034768 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Zheng Sun · 2023 to 2026
$1.9M
Circadian clock gene Rev-erb in memory dysfunction in Alzheimer's diseaseRF1AG069966 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SUN, ZHENG · 2021 to 2021
$1.8M
Chemically inducible split base editors for precise and controllable in vivo genome editingR01HL173243 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Xue Gao, Zheng Sun · 2025 to 2026
$1.3M
Circadian clock gene Rev-erb in memory dysfunction in Alzheimer's diseaseR01AG069966 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SUN, ZHENG · 2024 to 2025
$1.1M
American Diabetes Association ADA1-19-PDF-012Frank Belton Kimmel and Sandra Kimmel Endowed Post-Doctoral FellowshipGulf Coast Center for Precision Environmental Health GC-CPEHGulf Coast Center for Precision Environmental Health P30ES030285Gulf Coast Consortia (GCC) on the Training in Precision Environmental Health Sciences (TPEHS) Program T32ES027801Human Tissue Acquisition and Pathology Core at Baylor College of Medicine CA125123Intellectual and Developmental Disabilities Research Center P50103555National Institution on Aging AG069966National Natural Science Foundation of China 82371532NCI NIH HHS P30 CA125123Neurobehavioral Core at Baylor College of MedicineNHLBI NIH HHS HL173243NHLBI NIH HHS R01 HL173243NIA NIH HHS R01 AG069966NIA NIH HHS RF1 AG069966NIDDK NIH HHS P30 DK056338NIEHS NIH HHS ES034768NIEHS NIH HHS P30 ES030285NIEHS NIH HHS R01 ES034768NIEHS NIH HHS T32 ES027801Texas Medical Center Digestive Diseases Center P30DK056338
6 · The paper itself

Abstract

Nuclear receptor corepressors (NCOR1/2) mediate the transcriptional activity of methyl-CpG binding protein 2 (MECP2), and genetic variants in NCOR1/2 or MECP2 associate with autism or intellectual disability. However, it is unknown whether heterozygous NCOR mutations impair cognitive functions and how NCOR-related intellectual disability can be treated. Here, we constructed a knock-in (KI) mouse line carrying a heterozygous NCOR1 mutation (NCOR1 c.2182+2T>G) found in a pediatric patient. These NCOR1

Indexed as

allopregnanolonedownregulation and upregulationdrug repositioninghaploinsufficiencyintellectual disabilityknockout mousemecp2neuregulin 1neuroactive steroidspironolactone

Identifiers

PMID42860618
PMCPMC13655318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.